Get the Stockscreener App
2.44
0.41%
0.010
After Hours:
2.46
0.02
+0.82%
Heartbeam Inc stock is traded at $2.44, with a volume of 40,844.
It is up +0.41% in the last 24 hours and up +11.42% over the past month.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
See More
Previous Close:
$2.43
Open:
$2.4747
24h Volume:
40,844
Relative Volume:
0.60
Market Cap:
$64.81M
Revenue:
-
Net Income/Loss:
$-14.47M
P/E Ratio:
-1.5742
EPS:
-1.55
Net Cash Flow:
$-12.19M
1W Performance:
+1.24%
1M Performance:
+11.42%
6M Performance:
+10.41%
1Y Performance:
+83.46%
1-Day Range:
$2.4312
$2.4935
1-Week Range:
$2.38
$2.73
52-Week Range:
$1.06
$3.3893
Heartbeam Inc Stock (BEAT) Company Profile
Name
Heartbeam Inc
Sector
Industry
Phone
408-899-4443
Address
2118 WALSH AVE., SUITE 210, SANTA CLARA
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-20 | Initiated | Needham | Buy |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Aug-02-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-26-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-18 | Reiterated | Lake Street | Buy |
| Apr-26-18 | Reiterated | The Benchmark Company | Buy |
| Feb-23-18 | Reiterated | Dougherty & Company | Buy |
| Nov-08-17 | Reiterated | Dougherty & Company | Buy |
| Oct-26-17 | Initiated | Raymond James | Outperform |
| Oct-24-17 | Initiated | SunTrust | Buy |
| Aug-09-17 | Reiterated | Dougherty & Company | Buy |
| Jul-19-17 | Reiterated | The Benchmark Company | Buy |
| Apr-11-17 | Reiterated | Dougherty & Company | Buy |
| Dec-02-16 | Initiated | Dougherty & Company | Buy |
| Sep-13-16 | Initiated | Sidoti | Buy |
| Aug-03-16 | Reiterated | The Benchmark Company | Buy |
| Jul-28-15 | Reiterated | Dougherty & Company | Buy |
| Oct-24-13 | Initiated | The Benchmark Company | Buy |
| Aug-21-13 | Initiated | Dougherty & Company | Buy |
View All
Heartbeam Inc Stock (BEAT) Latest News
Spotlight On US Penny Stocks In October 2024 - Simply Wall St
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time - Business Wire
Tripp Investments Alters Stake in Betmakers - MSN
Severfield PLC Executes Share Buy-Back on LSE - MSN
HeartBeam, Inc. (BEAT): A Bull Case Theory - Insider Monkey
HeartBeam (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care - Barchart
Heartbeam Inc (BEAT-Q) QuotePress Release - The Globe and Mail
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards - Business Wire
HeartBeam Appoints Robert Eno as New CEO - TipRanks
Upstart Holdings, Inc. (UPST) Registers a Bigger Fall Than the Market: Important Facts to Note - MSN
Lifesaving Portable, AI Augmented Cardiac Monitoring - openPR
HeartBeam names Robert Eno as new CEO for growth phase - Investing.com
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization - Business Wire
HeartBeam names Robert Eno as new CEO for growth phase By Investing.com - Investing.com UK
Dr. Lance Myers Joins HeartBeam As Chief AI Scientist - MPO-mag
Dr. Lance Myers Joins HeartBeam as Chief AI Scientist - MPO-mag
Short Interest in HeartBeam, Inc. (NASDAQ:BEATW) Decreases By 17.6% - Defense World
HeartBeam appoints AI expert Lance Myers as Chief Scientist - Investing.com
HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist - Business Wire
Here's Why We're Watching HeartBeam's (NASDAQ:BEAT) Cash Burn Situation - Simply Wall St
Is HeartBeam (NASDAQ:BEAT) In A Good Position To Invest In Growth? - Yahoo Finance
Timothy Cruickshank named HeartBeam CFO - Medical Buyer
Heartbeam stock retains Speculative Buy rating despite near-term risks - Investing.com India
HeartBeam Names Timothy Cruickshank As CFO - MPO-mag
HeartBeam Appoints New CFO to Bolster Financial Strategy - TipRanks
HeartBeam names new CFO to bolster financial strategy By Investing.com - Investing.com Canada
HeartBeam names new CFO to bolster financial strategy - Investing.com
HeartBeam Names Timothy Cruickshank as Chief Financial Officer - StockTitan
HeartBeam stock target unchanged as Benchmark reiterates Speculative Buy rating - Investing.com
Heartbeam director sells over $4,900 in company stock - Investing.com
HeartBeam, Inc. (NASDAQ:BEATW) Short Interest Up 115.4% in August - Defense World
Heartbeam executive sells shares worth over $6,400 - Investing.com
HeartBeam (NASDAQ: BEAT) Announces Positive Study Data For Its AI Program - Barchart
Branislav Vajdic - Forbes
The Globe and Mail - The Globe and Mail
HeartBeam, Inc. (NASDAQ:BEAT) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: HeartBeam anticipates AIMIGo launch, reports $5M loss - Investing.com
Earnings call: HeartBeam anticipates AIMIGo launch, reports $5M loss By Investing.com - Investing.com UK
HeartBeam Reports Second Quarter 2024 Results - 01Net
BEATHeartBeam, Inc. Latest Stock News & Market Updates - StockTitan
HeartBeam, Inc. (NASDAQ:BEATW) Sees Large Drop in Short Interest - Defense World
HeartBeam to Host Virtual Roadshow Webinar on Tuesday September 20, 2022 at 4:30 p.m. Eastern Time - Quantisnow
HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time - Business Wire
Dow's 313-point rally highlighted by gains for Boeing, Amazon.com Inc. shares - MSN
HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias - Diagnostic and Interventional Cardiology
HeartBeam Inc's results are impressive – US Post News - US Post News
HeartBeam Inc (BEAT) Stock: Navigating a Year of Volatility - The InvestChronicle
HeartBeam Added to Russell Microcap® Index - Business Wire
HeartBeam announces appointment of Robert Eno to President - World Business Outlook
Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer - Quantisnow
HeartBeam Launches New Video Showcasing the HeartBeam AIMI™ and AIMIGo™ Technologies - Quantisnow
Heartbeam Inc Stock (BEAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.66%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):